Get notified when CPHI files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Previous Auditor (new) — The company changed auditors, which can signal accounting disagreements or concerns.
China Pharma Holdings files to sell up to $600,000 of common stock at market prices through Dec 31, 2024
Filed December 13, 2024 · ~2 min read
Key Changes
-
high
China Pharma Holdings may sell up to $600,000 of common stock to an institutional investor under a securities purchase agreement, with proceeds for general working capital.
The Offering verify on EDGAR → -
high
Purchase price is the lower of the prior day's close or the 5-day average, with a $0.15 floor, allowing the investor to buy at a discount to market.
The Offering verify on EDGAR → -
high
The investor can adjust the price downward if the market drops and can return shares before paying if conditions are unfavorable, shifting risk to the company.
Risk Factors verify on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (ORCL 10-Q) is open in full — no account needed.
Partner
Trade CPHI commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Sep 3, 2026 · How we verify